Spotlight on Two Breast Cancer Studies From the ASCO20 Virtual Scientific Program
Jul 12, 2023•12 min•Ep. 56
Episode description
This week, we'll review two influential breast cancer studies presented during the ASCO20 Virtual Scientific Program: MINDACT and HER2CLIMB.
"}" data-sheets-userformat= "{"2":769,"3":{"1":1},"11":4,"12":0}"> This week, we'll review two influential breast cancer studies presented during the ASCO20 Virtual Scientific Program: MINDACT and HER2CLIMB.For the best experience, listen in Metacast app for iOS or Android
